Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Interstate 280 Near Wolfe Road


Multiple Vehicles Involved in Fatal Cupertino Accident

Fatal Accident 6

Cupertino, CA (December 11, 2019) – One person was killed in a multi-vehicle crash in Cupertino. The fatal accident occurred on the morning of December 11 on Interstate 280.

Multiple vehicles collided on southbound Interstate 280, near Wolfe Road. One person was killed in the crash. Another person was taken into police custody. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Cupertino

#95014


January 17, 2020

1 Killed in Pedestrian Crash on 14 Freeway Near Avenue I

Victim Hit by Car in Fatal Lancaster Accident...


December 13, 2019

1 Injured in Crash on Highway 17 Near Lark Avenue

2 Trucks Collide in Los Gatos Accident...


May 7, 2020

Antonia Sisemore Dies From COVID-19 While Working at St. John’s Retirement Village

Outbreak at Woodland Nursing Home Claims Life of Nursing Assistant...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.